Involvement of circRNAs in the Development of Heart Failure
- PMID: 36430607
- PMCID: PMC9697219
- DOI: 10.3390/ijms232214129
Involvement of circRNAs in the Development of Heart Failure
Abstract
In recent years, interest in non-coding RNAs as important physiological regulators has grown significantly. Their participation in the pathophysiology of cardiovascular diseases is extremely important. Circular RNA (circRNA) has been shown to be important in the development of heart failure. CircRNA is a closed circular structure of non-coding RNA fragments. They are formed in the nucleus, from where they are transported to the cytoplasm in a still unclear mechanism. They are mainly located in the cytoplasm or contained in exosomes. CircRNA expression varies according to the type of tissue. In the brain, almost 12% of genes produce circRNA, while in the heart it is only 9%. Recent studies indicate a key role of circRNA in cardiomyocyte hypertrophy, fibrosis, autophagy and apoptosis. CircRNAs act mainly by interacting with miRNAs through a "sponge effect" mechanism. The involvement of circRNA in the development of heart failure leads to the suggestion that they may be promising biomarkers and useful targets in the treatment of cardiovascular diseases. In this review, we will provide a brief introduction to circRNA and up-to-date understanding of their role in the mechanisms leading to the development of heart failure.
Keywords: cardiac fibrosis; cardiac hypertrophy; circRNA; heart failure; miRNA sponge.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Advance in circular RNA modulation effects of heart failure.Gene. 2020 Dec;763S:100036. doi: 10.1016/j.gene.2020.100036. Epub 2020 Jul 24. Gene. 2020. PMID: 34493370 Review.
-
Circular RNA regulatory role in pathological cardiac remodelling.Br J Pharmacol. 2025 Jan;182(2):316-339. doi: 10.1111/bph.16434. Epub 2024 Jun 3. Br J Pharmacol. 2025. PMID: 38830749 Review.
-
Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis.Genomics. 2020 Mar;112(2):1680-1685. doi: 10.1016/j.ygeno.2019.10.006. Epub 2019 Oct 15. Genomics. 2020. PMID: 31626900 Review.
-
CircRNA Interference Pathway: A New Target for Intervention in Different Stages of Heart Failure.Curr Top Med Chem. 2024;24(17):1451-1463. doi: 10.2174/0115680266300535240514104107. Curr Top Med Chem. 2024. PMID: 38798203 Review.
-
Circular RNAs: a small piece in the heart failure puzzle.Funct Integr Genomics. 2024 May 17;24(3):102. doi: 10.1007/s10142-024-01386-z. Funct Integr Genomics. 2024. PMID: 38760573 Review.
Cited by
-
Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA/p47PHOX mediated ferroptosis.Cardiovasc Diabetol. 2024 Apr 15;23(1):129. doi: 10.1186/s12933-024-02204-3. Cardiovasc Diabetol. 2024. PMID: 38622592 Free PMC article.
-
Extracellular vesicular microRNAs and cardiac hypertrophy.Front Endocrinol (Lausanne). 2025 Jan 9;15:1444940. doi: 10.3389/fendo.2024.1444940. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39850481 Free PMC article. Review.
-
circRNA, a novel diagnostic biomarker for coronary heart disease.Front Cardiovasc Med. 2023 Feb 1;10:1070616. doi: 10.3389/fcvm.2023.1070616. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36818340 Free PMC article.
-
Circular RNAs in coronary heart disease: From molecular mechanism to promising clinical application (Review).Int J Mol Med. 2025 Jan;55(1):11. doi: 10.3892/ijmm.2024.5452. Epub 2024 Nov 8. Int J Mol Med. 2025. PMID: 39513584 Free PMC article. Review.
-
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction.Front Cardiovasc Med. 2024 Jan 8;10:1300375. doi: 10.3389/fcvm.2023.1300375. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38259314 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical